Evaluation of Pharmacokinetic Drug Interactions Between Gemigliptin (Dipeptidylpeptidase-4 Inhibitor) and Glimepiride (Sulfonylurea) in Healthy Volunteers

PURPOSE: Gemigliptin is approved for the treatment of type II diabetes mellitus. Sulfonylureas are commonly used in combination with other antidiabetic drugs to improve glycemic control. The objective of this study was to evaluate the pharmacokinetics, safety, and tolerability of gemigliptin and gli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Choi, Hee Youn, Kim, Yo Han, Kim, Mi Jo, Lee, Shi Hyang, Bang, Keunsu, Han, Song, Lim, Hyeong-Seok, Bae, Kyun-Seop
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2014
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153964/
https://ncbi.nlm.nih.gov/pubmed/24962635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-014-0054-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados